The American Journal of Managed Care

AUA Posters Highlight Racial Gaps in PSA Screening, Prostate Cancer Risk

Speakers discussed the disparities in prostate-specific antigen (PSA) screening rates among different racial groups and explored the potential of free PSA percentage as a predictive marker for future ...
Business Wire

Veracyte Announces Seven Posters Highlighting Clinical Value of Decipher Prostate Genomic Testing To be Presented at SUO 2023

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) today announced that seven posters will be presented at the 24th Annual Meeting of the Society of Urologic Oncology (SUO ...
Nasdaq

BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer

PHILADELPHIA and VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage ...
Nature

Does the PSA test for prostate cancer save lives? New data reverse gold-standard findings

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of ...
ascopubs.org

POSTER: Evaluating the impact of virtual peer-led support groups on prostate cancer survivorship—The AnCan experience.

Aggressive-variant prostate cancer features and therapeutic outcomes in patients with de-novo metastatic hormone-sensitive prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO ...